Novel Approaches & New Trends in Vaccines Development

Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine the discovery of novel antigens, adjuvants, and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines, and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design.

  • Antigen discovery
  • Immunological challenges
  • Aspects of pathology and host responses
  • Expanded testing and modelling of vaccine
  • Chloroplast-derived vaccines antigens and therapeutics

Related Conference of Novel Approaches & New Trends in Vaccines Development

August 12-13, 2019

34th World Congress on Vaccines and Immunization

Auckland, New Zealand
October 25-26, 2019

37thVaccination, Immunization & Antibiotics

Vancouver, Canada
November 12-13, 2019

35th World Vaccines & Immunization Congress

Brisbane, Australia
November 14-15, 2019

2nd International Conference on Vaccine Research

Geneva, Switzerland
November 21-22, 2019

International Conference on Vaccine and Vaccine research

Berlin,Germany

Novel Approaches & New Trends in Vaccines Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in